Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia.

scientific article published on 9 April 2010

Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1182/BLOOD-2009-11-252494
P698PubMed publication ID20382847
P5875ResearchGate publication ID43099827

P50authorAntonella ZucchettoQ42703050
Silvia MartinelliQ45958982
Giovanni Del PoetaQ56950902
Davide RossiQ89878155
Antonio CuneoQ91310932
Carla GuarnottaQ114406100
Elisa SozziQ114441832
Rita SantachiaraQ114528473
Stefania FiorcariQ114528530
Patrizia ZucchiniQ114528532
Gianluca GaidanoQ30303486
Francesco ForconiQ30303490
Valter GatteiQ30303512
Gian Matteo RigolinQ37830534
Claudio TripodoQ38317827
Rossana MaffeiQ38326918
Roberto MarascaQ38326950
P2093author name stringGiuseppe Torelli
Valeria Coluccio
Ilaria Castelli
Giovanna Leonardi
Marcella Fontana
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectleukemiaQ29496
lymphocyteQ715347
P304page(s)584-592
P577publication date2010-04-09
P1433published inBloodQ885070
P1476titleAngiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia.
P478volume116

Reverse relations

cites work (P2860)
Q37192643ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.
Q41208882Aggressive primary cutaneous B-cell lymphomas show increased Angiopoietin-2-induced angiogenesis
Q47119323Angiogenesis in adenosquamous cancer of pancreas
Q37043828Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer
Q28287317Angiopoietin signaling in the vasculature
Q48330774Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement
Q41758452Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis
Q84617608Angiopoietin-2 in CLL
Q40535831Angiopoietins Modulate Survival, Migration, and the Components of the Ang-Tie2 Pathway of Chronic Lymphocytic Leukaemia (CLL) Cells In Vitro
Q41045903Association of β2-microglobulin with the prognosis of non-Hodgkin's lymphoma: a meta analysis.
Q46211892Circulating angiopoietin-2, its soluble receptor Tie-2, and mortality in the general population
Q26830323Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia
Q28539394Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptor
Q37174690Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial
Q33416596FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia
Q36069142Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis
Q41374499MCPH1 maintains long-term epigenetic silencing of ANGPT2 in chronic lymphocytic leukemia
Q46666106Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report
Q36006453Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.
Q36121903Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis
Q37978344RNA-based markers as prognostic factors in chronic lymphocytic leukemia
Q38101997Targeting angiopoietin-2 signaling in cancer therapy
Q37774852Targeting the ANGPT-TIE2 pathway in malignancy
Q37859253The bone marrow stroma in hematological neoplasms--a guilty bystander.
Q36967153The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.
Q26753835The progress of angiogenic factors in the development of leukemias
Q39321127Therapeutic targeting of the angiopoietin-TIE pathway

Search more.